Amgen Inc (NASDAQ:AMGN)
| 251.38 Delayed Data As of May 14 |  -0.68 / -0.27%Today’s Change | 210.28 Today|||52-Week Range 276.69 | +9.33% Year-to-Date |
AMGN Regular Dividend: AMGN began trading ex-dividend on 05/14/21. A $1.76 dividend will be paid to shareholders of record as of 05/17/21.
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 252.06 |
| Today’s open | 253.31 |
| Day’s range | 251.11 - 254.47 |
| Volume | 145,642 |
| Average volume (3 months) | 2,727,706 |
| Market cap | $146.1B |
Data as of 4:29pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -4.37% |
| Earnings growth (this year) | -1.93% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | +8.53% |
| P/E ratio | 20.8 |
| Price/Sales | 5.37 |
| Price/Book | 15.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.35 | -0.51% |
| MRNAModerna Inc | +11.71 | +7.82% |
| ILMNIllumina Inc | +7.61 | +2.04% |
| BIIBBiogen | -1.28 | -0.45% |
Data as of 4:00pm ET, 05/14/2021
Financials
| Next reporting date | July 28, 2021 |
| EPS forecast (this quarter) | $4.04 |
| Annual revenue (last year) | $25.2B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 28.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
